Dr. Simon on Ensuring Health Equity in Cancer Care

Video

In Partnership With:

Melissa A. Simon, MD, discusses ensuring health equity in cancer care.

Melissa A. Simon, MD, vice chair for research, Department of Obstetrics and Gynecology, director, Institute for Public Health and Medicine (IPHAM), Center for Health Equity Transformation, George H. Gardner, MD, Professor of Clinical Gynecology, professor of obstetrics and gynecology (general obstetrics and gynecology)/preventive medicine and medical social sciences, Feinberg School of Medicine, Northwestern Medicine, co-chair, Health Equity Committee, ECOG-ACRIN Cancer Research Group, discusses ensuring health equity in cancer care.

The ECOG-ACRIN Health Equity Committee is long standing, and has evolved over the years, Simon says. The vision of the committee is to ensure health equity principles are embedded throughout the structure of both cancer care and health careoverall, Simon explains.

ECOG-ACRIN is a clinical trial research group and is a part of the National Cancer Institute clinical trials group, Simon continues. It remains important that in the conduct of clinical trials, equity is embedded into all aspects of studies, Simon concludes.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD